The U.S. FDA once again has a leadership gap at the top of its drug center, which already has been ravaged this year by massive terminations, resignations and retirements of senior leaders. George ...
George Tidmarsh, a biopharma industry veteran who’s helmed CDER for a little more than three months, resigned yesterday after being placed on administrative leave two days earlier amid a Health and ...
Green Matters on MSN
FDA Recalls More Than 140,000 Bottles of Cholesterol Medications Due to High Health Risk They Pose
Massive recall of 141,984 bottles of Cholesterol medicine gets an update. In September, the Food and Drug Administration ...
FDA Commissioner Marty Makary, M.D., has made his pick for the next director of the FDA’s Center for Drug Evaluation and Research (CDER) in veteran biotech executive George Tidmarsh, M.D., Ph.D.
A now-deleted LinkedIn post from a top FDA official has raised the hackles of Aurinia Pharmaceuticals as industry watchers puzzle over the official's decision to target the approvability of surrogate ...
Esteemed expert in the regulation and development of biopharmaceuticals, with more than three decades of experience spanning government, industry, and academia MIAMI, FL / ACCESS Newswire / August 21, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback